[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Laboratory Studies
July 1969

Site of Action of Methotrexate in Psoriasis

Author Affiliations

Newcastle upon Tyne, England; Uppsala, Sweden

From the University Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, England (Dr. Comaish) and the Department of Dermatology, University Hospital, Uppsala, Sweden (Dr. Juhlin).

Arch Dermatol. 1969;100(1):99-105. doi:10.1001/archderm.1969.01610250105024
Abstract

Methotrexate has little visible effect upon the psoriatic lesion when applied in aqueous cream or ointment under polythene occlusive dressings or when infused into the lesion over a period of three days. High concentrations (1%) in aqueous dimethyl sulfoxide when applied under polythene dressings caused pain, purpura, blisters and erosions in some patients. Less than 0.55% of methotrexate applied epicutaneously with occlusion was excreted in the urine over a period of 72 hours, and most of the methotrexate remained on or in the stratum corneum.

×